Trending Now

A drift-aware model picks rescue targets in mouse B cells

Memorial Sloan Kettering researchers built DynaVelo, a neural model that learns how…

A Singapore vision model reads 18 datasets and points at the evidence

Researchers at A*STAR and Singapore Eye Research Institute built a medical vision…

Parse and Nomic open a 100 million cell immune atlas for AI

The QIAGEN-owned single-cell company and proteomics startup Nomic Bio are building Cascade,…

Medicare’s AI pre-approval test cut targeted care by a fifth

The first study of Medicare's WISeR prior authorization pilot finds epidural steroid…

Setara opens with $90M built from Jazz Pharma pipeline

A new rare-disease biotech inherits the programs Jazz left behind, led by…

AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response

AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…

HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare

From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…

High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials

AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…

Pythia Labs emerges with an AI model that writes working antibodies

The startup's first proof of concept designed full-length human antibodies against 22 hard targets, including…

By

St Vincent’s convenes its own clinicians to police AI adoption

The Australian provider has seated a national council to decide which AI reaches patients, and…

By

Over 173 AI-designed drugs now in trials as FDA decision nears

More than 173 AI-originated drug programs are in clinical development as of early 2026, with…

By

12,000 voices shape UK plan for staged medical AI licenses

A doctor-led commission has handed the MHRA a roadmap that would put new medical AI…

By

AbbVie signs a multi-year AI deal as Iambic files for Nasdaq

The San Diego drug designer lands a large pharma partner days before asking public investors…

By

Armenia Launches First AI System to Analyze Lab Data, Ushering in a New Era of Preventive Healthcare

A groundbreaking collaboration between Docus and Blood Cells lab network is transforming how Armenian citizens…

Merck confirms drug design from Stanford’s 37,000-agent virtual biotech

Stanford's virtual biotech of 37,000 AI agents designed a lung cancer drug that Merck later…

By

ARPA-H Awards $160 Million for AI-Enabled Personalized Gene Editing to Tackle Rare Diseases

ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms…

By